www.frontiersin.org
Frontiers | Physician and hospital determinants of levothyroxine treatment adequacy in low-risk papillary thyroid carcinoma
BackgroundFor low-risk differentiated thyroid carcinoma (DTC) survivors with excellent or indeterminate response, the 2025 American Thyroid Association (ATA)...